SFM
BIIB icon

Signet Financial Management’s Biogen BIIB Stock Holding History

Signet Financial Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7
Closed -$2K – 371
2021
Q4 		$2K Buy
+7
New +$1.8K ﹤0.01% 1303
2021
Q2 		– Sell
-4,119
Closed -$1.15M – 133
2021
Q1 		$1.15M Buy
4,119
+571
+16% +$154K 0.22% 112
2020
Q4 		$869K Sell
3,548
-813
-19% -$210K 0.18% 118
2020
Q3 		$1.55M Sell
4,361
-261
-6% -$72.8K 0.34% 84
2020
Q2 		$1.39M Sell
4,622
-646
-12% -$194K 0.31% 89
2020
Q1 		$1.69M Sell
5,268
-317
-6% -$96.2K 0.4% 80
2019
Q4 		$1.66M Sell
5,585
-407
-7% -$113K 0.31% 95
2019
Q3 		$1.76M Sell
5,992
-318
-5% -$74K 0.34% 90
2019
Q2 		$1.5M Sell
6,310
-679
-10% -$157K 0.3% 95
2019
Q1 		$1.61M Sell
6,989
-394
-5% -$124K 0.32% 96
2018
Q4 		$2.22M Buy
+7,383
New +$2.36M 0.48% 79
2016
Q2 		– Sell
-998
Closed -$260K – 175
2016
Q1 		$260K Hold
998
– – 0.05% 152
2015
Q4 		$306K Buy
+998
New +$287K 0.06% 146

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Signet Financial Management's BIIB Position: Q1 2022 in Review

Signet Financial Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 7 shares — an estimated $2K sold.

Signet Financial Management first reported a position in BIIB in Q4 2015 and held it in 13 quarters. The position peaked at $2.22M in Q4 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Signet Financial Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 7 Biogen shares in Q1 2022, an estimated $2K.
  • Signet Financial Management first reported a position in Biogen in Q4 2015 and held it in 13 quarters.
  • Signet Financial Management's Biogen position peaked at $2.22M in Q4 2018.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.